Probiotics and prebiotics play significant roles in managing Inflammatory Bowel Disease (IBD), which includes Crohn's disease and ulcerative colitis. Probiotics, live beneficial bacteria, help restore the gut microbiota balance disrupted by IBD. They may alleviate symptoms such as diarrhea and inflammation by competing with pathogenic bacteria and enhancing the gut’s immune response. Common strains used in IBD management include Lactobacillus and Bifidobacterium. Prebiotics, non-digestible fibers, nourish these beneficial bacteria, promoting their growth and activity. They can improve gut health and potentially reduce inflammation. While some studies suggest benefits, the efficacy of probiotics and prebiotics can vary based on individual conditions and specific strains used. It is crucial for patients to consult healthcare providers before starting any probiotic or prebiotic regimen to ensure it complements their treatment plan and addresses their unique needs.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India